Prasugrel Versus Double Dose Clopidogrel to Treat Clopidogrel Low-responsiveness After PCI
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 106 participants.
Also called NCT01135667
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 106 participants
- Sponsor
- Lene Holmvang
- Registry
-
NCT01135667
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Denmark
- Registry status
- Completed
Technical summary
Registry record NCT01135667. Randomized; no masking; primary purpose treatment. Start 2010-09 (registry gives no type); primary completion 2012-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Prasugrel Versus Double Dose Clopidogrel to Treat Clopidogrel Low-responsiveness After PCI
- Acronym
- TAILOR
- Condition
- Coronary Artery Disease
- Condition
- Percutaneous Coronary Intervention
- Condition
- Acute Coronary Syndromes
- Intervention (Drug)
- clopidogrel
- Intervention (Drug)
- Prasugrel 10 mg
- Lead sponsor
- Lene Holmvang
Record details
- Record id
cardio:ct-nct01135667- Content hash
593012e213ba01c6a4cc747b3ef2f2bb7cbf6489990d4198eed7a1820014447c